Repligen Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Repligen

Access the complete profile.

Repligen Fast Facts

Revenue	Over $500 million    See Exact Annual Revenue
Employees	Over 1,000Exact Company Size
Primary Industry	3254 Pharmaceutical & Medicine Manufacturing
Address	41, Seyon Street, Suite 100 Waltham, Massachusetts,united States, MA 02453

Note: Revenues for privately held companies are statistical evaluations.


Repligen's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Repligen's annual revenues are Over $500 million (see exact revenue data)
• What industry is the company in?
  • Repligen is classified as operating in the Pharmaceutical & Medicine Manufacturing industry, NAICS Code 3254.

Repligen Annual Revenue and Growth Rate

Repligen	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	Over $500 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Repligen's revenues are gauged from an analysis of company filings.

Repligen's Income Statement (based on Industry Averages)

Repligen P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Repligen is developing and marketing. Repligen doesn't have any recent trademark applications, indicating Repligen is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
ARTESYN Control valves for regulating the flow of gases and liquids; fluid handling devices, namely, electro-mechanical valves for controlling fluids for disposable or single use bioprocessing applications, and parts therefor; valve systems used for handling fluids for disposable or single use bioprocessing applications comprised of valves, valve bodies, conduits, jackets and parts therefor.	05/07/2021
ROBOCOLUMN Chromatography apparatus for laboratory use	03/23/2021
SPECTRAFLO Laboratory apparatus, namely, molecular separation, purification and dialysis systems comprising dialysis tanks, pumps, reservoirs, membranes and tubing, and their structural parts for laboratory and biopharmaceutical processing use	04/18/2019

See all trademarks and details in the Full Report.

Market Share of Repligen's Largest Competitors

A competitive analysis shows these companies are in the same general field as Repligen, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
PFIZER	New York, NY	100
ABBOTT LABORATORIES	Abbott Park, IL	78
BRISTOL-MYERS SQUIBB	Lawrenceville, NJ	78
ELI LILLY	Indianapolis, IN	59
MERCK SHARP & DOHME	Rahway, NJ	56
CSL BEHRING	King Of Prussia, PA	55
CSLB HOLDINGS	King Of Prussia, PA	54
MERCK	Rahway, NJ	53
ALLERGAN	North Chicago, IL	53

Nearby Competitors

These companies are similar in business line and location to Repligen. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
REPLIGEN	Waltham, Massachusetts,united States, MA	100
APELLIS PHARMACEUTICALS	Waltham, MA	67
CUBIST PHARMACEUTICALS	Lexington, MA	59
BIOVERATIV U.S. LLC.	Waltham, MA	58
ABCAM	Waltham, MA	29
KARYOPHARM THERAPEUTICS	Newton, MA	25

Future Competition: Repligen's Fastest Growing Competitors

These companies are in the same general field as Repligen and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)